Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I)

Clinical trial NCT05169957 · COMPLETED

Trial details

NCT number: NCT05169957
Sponsor: University of Michigan Rogel Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma, Ocular Melanoma, Cutaneous Metastatic Melanoma Melanoma, Mucosal Liver Metastases

Start date: 2022-08-09
Primary completion: 2023-06-13
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.